Ascendis Pharma (ASND) PT Lowered to $326 at Wells Fargo
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $274.50 +2.51%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Wells Fargo analyst Chris M. Carey lowered the price target on Ascendis Pharma (NASDAQ: ASND) to $326.00 (from $330.00) while maintaining a Overweight rating.
You May Also Be Interested In
- JPMorgan Upgrades Bajaj Housing Finance (BAJAJHFL:IN) to Neutral
- BYD Co Ltd (1211:HK) (BYDDF) PT Lowered to HK$113 at Macquarie
- Asymchem Laboratories Tianjin Co Ltd (002821:CH) PT Raised to RMB172 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
